Literature DB >> 9743339

Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.

P Kaliński1, J H Schuitemaker, C M Hilkens, M L Kapsenberg.   

Abstract

Activation of immature dendritic cells (DC) in peripheral tissues induces their migration to lymph nodes and their maturation into CD83+ DC, which are able to prime naive T cells. The inflammatory cytokines IL-1beta and TNF-alpha induce mature DC, which can secrete IL-12 and promote the development of Th0/Th1-biased cells. DC maturation factors with a Th2-promoting function have not been described. Here we show that PGE2, although it does not induce final DC maturation by itself, synergizes with IL-1beta and TNF-alpha, and allows their effectiveness at 100-fold lower concentrations. While being phenotypically identical with the DC matured in the presence of high concentrations of IL-1beta and TNF-alpha alone, DC matured in the additional presence of PGE2 show impaired IL-12 production and bias naive Th cell development toward the Th2. The ability of DC to produce IL-12 is also suppressed by IL-10, which in contrast to PGE2, inhibits their maturation. The differences in the ability to produce IL-12, established during the final DC maturation, are stable after the removal of modulatory factors. Importantly, fully mature DC become unsusceptible to PGE2 and IL-10. This indicates that the levels of IL-12 production in vivo, in mature DC interacting with Th cells within the lymph nodes, are mainly predetermined at the stage of immature DC in peripheral tissues. These data imply that the character of pathogen-induced local inflammatory reaction can "instruct" local DC to initiate Th1 or Th2-biased responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743339

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies.

Authors:  R Jotwani; A K Palucka; M Al-Quotub; M Nouri-Shirazi; J Kim; D Bell; J Banchereau; C W Cutler
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 3.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

4.  Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.

Authors:  Camilo E Fadul; Jan L Fisher; Thomas H Hampton; Enrico C Lallana; Zhongze Li; Jiang Gui; Zbigniew M Szczepiorkowski; Tor D Tosteson; C Harker Rhodes; Heather A Wishart; Lionel D Lewis; Marc S Ernstoff
Journal:  J Immunother       Date:  2011-05       Impact factor: 4.456

5.  Memory CD8+ T cells protect dendritic cells from CTL killing.

Authors:  Payal B Watchmaker; Julie A Urban; Erik Berk; Yutaro Nakamura; Robbie B Mailliard; Simon C Watkins; S Marieke van Ham; Pawel Kalinski
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

6.  Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application.

Authors:  H R Bohnenkamp; T Noll
Journal:  Cytotechnology       Date:  2003-09       Impact factor: 2.058

7.  Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors.

Authors:  Ester Sciaraffia; Antonella Riccomi; Ragnar Lindstedt; Valentina Gesa; Elisa Cirelli; Mario Patrizio; Maria Teresa De Magistris; Silvia Vendetti
Journal:  J Leukoc Biol       Date:  2014-03-20       Impact factor: 4.962

8.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Authors:  Rongxin Zhang; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 9.  Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4.

Authors:  Pawel Kalinski
Journal:  Curr Opin Investig Drugs       Date:  2009-06

10.  Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Authors:  Brooke M Helfer; Anthony Balducci; Aaron D Nelson; Jelena M Janjic; Roberto R Gil; Pawel Kalinski; I Jolanda M de Vries; Eric T Ahrens; Robbie B Mailliard
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.